Evidence map›Paper›PMID 34103004›Full record

ArticleBMC bioinformatics2021

Analysis of single-cell RNA sequencing data based on autoencoders.

Andrea Tangherloni, Federico Ricciuti, Daniela Besozzi, Pietro Liò, Ana Cvejic

Abstract read
In one paragraph

Article in BMC bioinformatics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Neoantigen-specific CD4Cancer cell · 2022
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Andrea TangherloniWellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, CB2 0AW, UK. andrea.tangherloni@unibg.it.
Federico RicciutiDepartment of Informatics, Systems and Communication, University of Milano-Bicocca, Milan, Italy.
Daniela BesozziDepartment of Informatics, Systems and Communication, University of Milano-Bicocca, Milan, Italy.
Pietro Liò *Department of Computer Science and Technology, University of Cambridge, Cambridge, CB3 0FD, UK. pl219@cam.ac.uk.
Ana Cvejic *Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, CB2 0AW, UK. as889@cam.ac.uk.

Funding

Cancer Research UK 14953Medical Research Council MC_PC_17230
6 · The paper itself

Abstract

backgroundSingle-cell RNA sequencing (scRNA-Seq) experiments are gaining ground to study the molecular processes that drive normal development as well as the onset of different pathologies. Finding an effective and efficient low-dimensional representation of the data is one of the most important steps in the downstream analysis of scRNA-Seq data, as it could provide a better identification of known or putatively novel cell-types. Another step that still poses a challenge is the integration of different scRNA-Seq datasets. Though standard computational pipelines to gain knowledge from scRNA-Seq data exist, a further improvement could be achieved by means of machine learning approaches.

resultsAutoencoders (AEs) have been effectively used to capture the non-linearities among gene interactions of scRNA-Seq data, so that the deployment of AE-based tools might represent the way forward in this context. We introduce here scAEspy, a unifying tool that embodies: (1) four of the most advanced AEs, (2) two novel AEs that we developed on purpose, (3) different loss functions. We show that scAEspy can be coupled with various batch-effect removal tools to integrate data by different scRNA-Seq platforms, in order to better identify the cell-types. We benchmarked scAEspy against the most used batch-effect removal tools, showing that our AE-based strategies outperform the existing solutions.

conclusionsscAEspy is a user-friendly tool that enables using the most recent and promising AEs to analyse scRNA-Seq data by only setting up two user-defined parameters. Thanks to its modularity, scAEspy can be easily extended to accommodate new AEs to further improve the downstream analysis of scRNA-Seq data. Considering the relevant results we achieved, scAEspy can be considered as a starting point to build a more comprehensive toolkit designed to integrate multi single-cell omics.

Indexed as

RNASingle-Cell AnalysisExome SequencingMachine LearningSequence Analysis, RNARNAAutoencodersBatch correctionClusteringData integrationDimensionality reductionscRNA-Seq

Identifiers

PMID34103004
PMCPMC8186186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.